The largest database of trusted experimental protocols

7 protocols using cd95 apc

1

Immunosenescent Cell Analysis in Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
UCLA Immune Assessment Core performed the analysis of immunosenescent cells for 144 whole blood samples, as described previously [71 (link)]. Briefly, Total CD3 + T-cells, CD4 + T-cells, CD8 + T-cells, CD19 + B-cells, and CD56 + /CD16 + NK-cells were enumerated in EDTA whole blood with the BD Multitest 6-color TBNK reagent and BD Trucount tubes following the manufacturer’s instructions, acquired on a BD FACSCanto II and analyzed with the BD FACSCanto Software. CD8 + T-cell sub setting was performed by staining 50 μl of EDTA whole blood with CD3 FITC, CD8 PerCP, CD28 PE, and CD95 APC (BD) for 10 min, followed by BD FACS Lysing used according to the manufacturer’s instructions. At least 10,000 lymphocyte events per sample were acquired and analyzed using DIVA 8.0 software on BD FACSCanto II.
+ Open protocol
+ Expand
2

Flow Cytometric Analysis of Lymphocyte Phenotypes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved PBMCs collected at T0 and T12 were thawed and stained (1x106 cells) with fluorochrome-labelled antibodies for the flow cytometric study of lymphocyte surface phenotypes. To check cell viability, cells were stained with 7-aminoactynomycin D (7-AAD, BD Biosciences, San Jose, California, USA) for 30 min in the dark at 4°C. Only samples with cellular viability greater than 70% were used for experiments.
The following antibodies were used: HLA-DR-FITC, CD38-PE, CCR7-PeCy7, CD45RA-PeCy5, CD27-PE, CD95-APC, α4β7integrin-APC CCR6-PeCy7, CD161-APC (BD Biosciences, San Jose, California, USA), CCR9-FITC (R&D Systems, Minneapolis, MN, USA).
We evaluated CD4+ and CD8+ activation (HLA-DR+CD38+), maturation (naïve: CCR7+CD45RA+; central memory: CCR7+CD45RA-; effector memory: CCR7-CD45RA-; terminally differentiated: CCR7-CD45RA+) and stem cell-like memory T cells (Tscm; CCR7+CD45RA+CD27+CD95+). CD4+ T-cell populations involved in mucosal immunity (CCR9+α4β7+; CCR6+CD161+) were also studied.
Cells were run on a FACS VERSE cytometer (BD Biosciences, San Jose, California, USA).
+ Open protocol
+ Expand
3

Mesenchymal Stem Cell Surface Marker Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression of surface markers associated with mesenchymal stem cells, such as CD13, CD34, CD44, CD45, CD95, CD105, HLA-DR and HLA-ABC, was evaluated by flow cytometry. Cultured cells at passage number 9 were detached from dishes with nonenzymatic cell dissociation solution (Sigma) and washed twice in PBS at room temperature. Cell pellets containing 2.5 × 105 cells were resuspended in 0.1 mM PBS and then incubated with isotype control IgG or specific antibodies, including CD-34, CD-44 and 90-PE (BD Biosciences, San Jose, CA, USA), CD-95-APC (BD Biosciences), CD-45-FITC, HLA-ABC-FITC and HLA-DR-FITC (BD Biosciences). A total of 1 × 104 cells were analyzed using a FACScan flow cytometer (BD Biosciences) and quantified with CellQuest Pro Software (BD Biosciences).
+ Open protocol
+ Expand
4

Comprehensive Immune Cell Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following conjugated antibodies were used for cell-surface staining: CD3-Pacific Blue (BD Pharmingen; Clone UCHT1; Cat. No. 558117; San Diego, CA, USA), CD8-APC H7 (BD Pharmingen; Clone SK1; Cat. No. 641400), CD45RA-PE (BD Pharmingen; Clone HI100; Cat. No. 555489), CCR7-PE-Cy7 (BD Pharmingen; Clone 3D12; Cat. No. 557648), CD28-PerCP-Cy5.5 (BD Biosciences; Clone L293; Cat. No. 337181; San Jose, CA, USA), CD27-Alexa Fluor 700 (BD Pharmingen; Clone M-T271; Cat. No. 560611), CD95-APC (BD Pharmingen; Clone DX2; Cat. No. 558814) and CD127-FITC (BD Pharmingen; Clone HIL-7R-M21; Cat. No. 560549). Conjugated antibodies for intracellular staining included the following: IFN-γ-FITC (BD Pharmingen; Clone 4S.B3; Cat. No. 554551), IL-2-PerCP-Cy5.5 (BD Pharmingen; Clone MQ1-17H12; Cat. No. 560708) and TNF-α-AlexaFluor 700 (BD Pharmingen; Clone MAb11; Cat. No. 557996). To exclude dead cells, the Fixable Aqua Dead Cell Stain viability marker was used (Invitrogen; Cat. No. L34957; Eugene, OR, USA).
+ Open protocol
+ Expand
5

PBMC Stimulation Assay with HIV Antigens

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMC between 600,000 and 1,000,000 were incubated with gag protein and HIV-1 Consensus B Gag peptide pools (The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: HIV-1 Con B Gag Peptide Pool [cat #12425]) or gp 120 protein for 9 hours with brefeldin A (Sigma, US), CD49d, and CD28 (BD Biosciences, US) at 37°C with 5% CO2. Cells were washed and stained with LIVE/DEAD -Aqua Viability fixable cell stain (Invitrogen, US), then washed and stained for extracellular markers with CD3-Pacific Blue, CD4-PerCP Cy5.5, and CD95-APC [BD Biosciences, US]. Cells were permeabilized with Fix Perm and stained for markers and intracellular cytokines with CD69-Texas Red, CD8-APC-H7, IL-2- PE, IFN-γ-Alexa 700, and TNF-α-PE-Cy7 (BD Biosciences, US). Cells were collected on an LSR-II (BD Biosciences, US) and analyzed using a FlowJo device (Treestar, US). All of the data shown have the ‘Mock’ stimulated background responses subtracted.
+ Open protocol
+ Expand
6

Flow Cytometric Analysis of T Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole blood was stained for flow cytometry as previously described (38 (link), 68 (link)). mAbs used were as follows: CD3- FITC (clone SP34) or CD3-PerCP (clone SP34-2); CD20-PE (clone 2H7); CD8-PErCP (clone SK1) or CD8-PE (clone RPA-T8); CD4-APC (clone L200) or CD4-PerCP (clone L200); HLA-DR-PerCP (clone L243); CD95-FITC (clone DX2) or CD95-APC (clone DX2); CD28-APC (clone CD28.2) or CD28-PE (clone CD28); Ki-67–FITC (clone B56); CD25-FITC (anti–IL-2 receptor) (clone 2A3); and FoxP3–Alexa Fluor 488 (clone 259D.C7) (all from BD Biosciences). All Abs were validated and titrated using AGM PBMCs. Data were acquired with an LSR II flow cytometer (BD Biosciences) and analyzed with CellQuest software (BD Biosciences). CD4+ and CD8+ T cell percentages were obtained by first gating on lymphocytes and then on CD3+ T cells. Memory, activation, and proliferation markers were determined by gating on lymphocytes, then on CD3+ T cells, and finally on CD4+CD3+ or CD8+CD3+ T cells. Gating strategy for Tregs is presented in Supplemental Figure 6, while the gating strategy for macrophages is presented in Supplemental Figure 7.
+ Open protocol
+ Expand
7

Immune Cell Phenotyping Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
UCLA Immune Assessment Core performed the analysis of immunosenescent cells. Total CD3 + T cells, CD4 + T cells, CD8 + T cells, CD19 + B cells, and CD56 + /CD16 + NK cells were enumerated in EDTA whole blood with the BD Multitest 6-color TBNK reagent and BD Trucount tubes following the manufacturer's instructions, acquired on a BD FACSCanto II and analyzed with the BD FACSCanto Software. CD8 + T cell sub setting was performed by staining 50 μl of EDTA whole blood with CD3 FITC, CD8 PerCP, CD28 PE, and CD95 APC (BD) for 10 minutes, followed by BD FACS Lysing used according to the manufacturer's instructions. At least 10,000 lymphocyte events per sample were acquired and analyzed using DIVA 8.0 software on BD FACSCanto II. The gating strategy used in the enumeration of CD8 + CD28 -is summarized in Figure S1.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!